R. Feldman

发表

Randomized Controlled Trial of E-Counseling for Hypertension: REACH

G. Eysenbach, R. Nolan, S. Barr, 2018, Circulation. Cardiovascular quality and outcomes.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Alexander G Logan, Simon L Bacon, Michael D Hill, 2018, The Canadian journal of cardiology.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2013, The Canadian journal of cardiology.

A randomized study comparing a patient-directed hypertension management strategy with usual office-based care.

K. Zarnke, B. Feagan, R. Feldman, 1997, American journal of hypertension.

The 2001 Canadian hypertension recommendations: take-home messages.

N. Campbell, R. Feldman, D. Drouin, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Hypertension in Canada and the Global Context. The Wine Is Vintage and the Glass Is Two-Thirds Full, but Is the Bottle Empty?

N. Campbell, R. Feldman, 2016, The Canadian journal of cardiology.

Intraclass differences among antihypertensive drugs.

F. McAlister, R. Padwal, R. Feldman, 2015, Annual review of pharmacology and toxicology.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2013, The Canadian journal of cardiology.

The impact of the Canadian Hypertension Education Programme in its first decade.

F. McAlister, R. Brant, N. Campbell, 2009, European heart journal.

Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly.

R. Feldman, D. Robertson, L. Limbird, 1984, The New England journal of medicine.

In vivo regulation of beta-adrenergic receptors on human mononuclear leukocytes: assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion.

H. Motulsky, A. Maisel, C. Lai, 1986, The Journal of clinical endocrinology and metabolism.

Are lymphocyte beta-adrenoceptors altered in patients with cystic fibrosis?

R. Feldman, R. Fick, C. C. Lai, 1987, Clinical science.

Quinapril treatment enhances vascular sensitivity to insulin

R. Feldman, N. D. Schmidt, 2001, Journal of hypertension.

The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.

E. Schiffrin, F. McAlister, R. Touyz, 2002, The Canadian journal of cardiology.

Development of a Computer‐Based Instructional System in Pharmacokinetics: Efficacy in Clinical Pharmacology Teaching for Senior Medical Students

R. Feldman, R D Feldman, R Schoenwald, 1989, Journal of clinical pharmacology.

Clinical Pharmacology and Therapeutics Education for Senior Medical Students

M. Albanese, R. Roberts, R. Feldman, 1987, Journal of clinical pharmacology.

Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.

P. Ravani, S. Rabkin, R. Quinn, 2014, The Canadian journal of cardiology.

G-Protein-coupled receptor kinase activity in hypertension : increased vascular and lymphocyte G-protein receptor kinase-2 protein expression.

J. Benovic, M. D. Meek, S. Ferguson, 2000, Hypertension.

G-protein-coupled receptor kinase activity is increased in hypertension.

J. Benovic, R. Feldman, R. Gros, 1997, The Journal of clinical investigation.

Aldosterone Regulates Vascular Reactivity: Short-Term Effects Mediated by Phosphatidylinositol 3-Kinase–Dependent Nitric Oxide Synthase Activation

R. Feldman, R. Gros, Selina L. Liu, 2003, Circulation.

G-protein polymorphisms and maternal/neonatal metabolism: still a weight for the answer

R. Hegele, R. Feldman, 2000, The Lancet.

The Canadian Hypertension Education Program Recommendations: what's new, what's old but still important in 2003.

R. Feldman, 2003 .

1999 Canadian recommendations for the management of hypertension including Case-based applications of the recommendations

Lawrence A Leiter, R. Haynes, J. Spence, 1999 .

Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients

B. Hemmelgarn, R. Feldman, S. Grover, 2005, Canadian Medical Association Journal.

Managing hypertension in patients with renal disease and diabetes

R. Feldman, N. Campbell, P. Larochelle, 2000 .

The 1999 Canadian recommendations for the management of hypertension. On behalf of the Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

R. Feldman, 1999, The Canadian journal of cardiology.

2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations.

F. McAlister, M. Lebel, N. Campbell, 2010, The Canadian journal of cardiology.

Extent of Vascular Remodeling Is Dependent on the Balance Between Estrogen Receptor &agr; and G-Protein–Coupled Estrogen Receptor

J. Pickering, R. Feldman, R. Gros, 2016, Hypertension.

SELF CARE-BASED MANAGEMENT OF HYPERTENSION: A WORK-IN-PROGRESS - Selfcare Journal

R. Feldman, 2015 .

Increasing appreciation for the role of single-pill combinations for the prevention of atherosclerotic disease: a pro-polypill polemic.

S. Nattel, R. Feldman, 2014, The Canadian journal of cardiology.

Postgame wrap of the ultimate blood pressure megatrial: did it score an ALLHAT trick or was it "three strikes and you're out?".

F. McAlister, R. Feldman, 2009, Hypertension.

A strategy to improve hypertension control: The Canadian experience

F. McAlister, S. Rabkin, R. Feldman, 2010 .

Canadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada.

N. Campbell, R. Feldman, Katherine Wyard, 2008, The Canadian journal of cardiology.

Dietary salt restriction increases vascular insulin resistance

A. Logan, R. Feldman, N. D. Schmidt, 1996, Clinical pharmacology and therapeutics.

Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Lawrence A Leiter, R. Ogilvie, E. Burgess, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Insulin-mediated vasodilation: impairment with increased blood pressure and body mass

R. Feldman, G. S. Bierbrier, Ross D. Feldman, 1993, The Lancet.

Leukocyte :-Receptor Alterations in Hypertensive Subjects

R. Feldman, L. Limbird, A. Wood, 2013 .

Scientific Contributions Human Insulin-Mediated Enhancement of Vascular / 3-Adrenergic Responsiveness

R. Feldman, R. Gros, K. Borkowski, 2005 .

Human insulin-mediated enhancement of vascular beta-adrenergic responsiveness.

R. Feldman, R. Gros, K. Borkowski, 1994, Hypertension.

Parallel regulation of the local vascular and systemic metabolic effects of insulin.

I. Hramiak, D. Finegood, R. Feldman, 1995, The Journal of clinical endocrinology and metabolism.

Insulin‐mediated sensitization of adenylyl cyclase activation

R. Feldman, 1993, British journal of pharmacology.

A Low‐Sodium Diet Corrects the Defect in β‐Adrenergic Response in Older Subjects

R. Feldman, 1992, Circulation.

Alterations in leukocyte β-receptor affinity with aging: a potential explanation for altered β-adrenergic sensitivity in the elderly

R. Feldman, D. Robertson, L. Limbird, 1984 .

The rise and fall of hypertension control in Canada. The beginning of the end or the end of the beginning?

R. Padwal, R. Feldman, S. Tobe, 2021, The Canadian journal of cardiology.

Usefulness of the Aldosterone-to-Renin Ratio for Screening Primary Aldosteronism Diastolic Dysfunction in Hypertensive Heart Disease

R. Haynes, E. Schiffrin, A. Logan, 2003 .

Adrenergic receptor polymorphisms and cardiac function (and dysfunction): a failure to communicate?

R. Feldman, 2001, Circulation.

β-Arrestins regulate a Ral-GDS–Ral effector pathway that mediates cytoskeletal reorganization

P. H. Anborgh, S. Ferguson, R. Feldman, 2002, Nature Cell Biology.

Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Cana

R. Petrella, R. Feldman, J. Cléroux, 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Direct angiotensin converting enzyme inhibitor—mediated venodilation

K. Zarnke, R. Feldman, 1996, Clinical pharmacology and therapeutics.

Sixty Years of Pharmacological Reviews: Has The Role of Review Articles in Biomedical Sciences Changed and, If So, How Does This Affect Pharmacological Reviews?

R. Feldman, E. Brass, 2009, Pharmacological Reviews.

Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1

D. Kelvin, S. Ferguson, R. Feldman, 2000, Nature Immunology.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Alexander G Logan, Michael D Hill, Pierre Larochelle, 2009 .

G protein alterations in hypertension and aging.

R. Feldman, J. Chorazyczewski, C. Tan, 1995, Hypertension.

Differential effect of intravenous procainamide on anterograde and retrograde accessory pathway refractoriness.

G. Klein, R. Yee, R. Feldman, 1992, Journal of the American College of Cardiology.

Moderate dietary salt restriction increases vascular and systemic insulin resistance.

R. Feldman, N. D. Schmidt, 1999, American journal of hypertension.

Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.

D. Kelvin, S. Ferguson, R. Feldman, 2000, Nature immunology.

Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes.

G. Hunninghake, R. Feldman, W. McArdle, 1987, Journal of immunology.

Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.

R. Feldman, R. Gros, J. Chorazyczewski, 2013, American journal of physiology. Cell physiology.

G‐Protein–coupled receptor kinase expression in hypertension

J. Benovic, D. Kelvin, R. Feldman, 1999, Clinical pharmacology and therapeutics.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

E. Schiffrin, B. Hemmelgarn, K. Mann, 2005, The Canadian journal of cardiology.

CHEMOKINES Metalloproteinases Are Involved in Lipopolysaccharide– and Tumor Necrosis Factor- a –Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression

D. Kelvin, J. Madrenas, R. Feldman, 1999 .

Impaired vasodilator function in hypertension: the role of alterations in receptor-G protein coupling.

R. Feldman, R. Gros, 1998, Trends in cardiovascular medicine.

The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

E. Schiffrin, F. McAlister, B. Hemmelgarn, 2004, The Canadian journal of cardiology.

Physiological regulation of beta-receptors in man.

R. Feldman, A. Wood, J. Nadeau, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

The interaction of verapamil and norverapamil with beta-adrenergic receptors.

C. Lai, R. Feldman, G. Park, 1985, Circulation.

Increased Enzyme Activity and &bgr;-Adrenergic–Mediated Vasodilation in Subjects Expressing a Single-Nucleotide Variant of Human Adenylyl Cyclase 6

R. Hegele, S. Van Uum, J. Pickering, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.

R. Feldman, 1990, The Journal of clinical investigation.

Vanadate stimulation of adenylyl cyclase: An index of tyrosine kinase vascular effects

R. Feldman, J. Chorazyczewski, Christopher M. Tan, 1999, Clinical pharmacology and therapeutics.

Defective vasodilatory mechanisms in hypertension: a G-protein-coupled receptor perspective

R. Feldman, R. Gros, 2006, Current opinion in nephrology and hypertension.

GPER-independent effects of estrogen in rat aortic vascular endothelial cells

R. Feldman, R. Gros, Q. Ding, 2015, Molecular and Cellular Endocrinology.

Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects.

R. Feldman, W. Lawton, W. McArdle, 1987, The Journal of clinical investigation.

THERAPY AND PREVENTION

C. Lai, R. Feldman, G. Park, 2005 .

Characterization of the human lymphocyte beta-adrenergic receptor by photoaffinity labeling. Alterations with desensitization.

C. Lai, R. Feldman, 1986, Circulation research.

Leukocyte beta-receptor alterations in hypertensive subjects.

R. Feldman, D. Robertson, L. Limbird, 1984, The Journal of clinical investigation.

Adherence to pharmacologic management of hypertension.

N. Campbell, R. Feldman, A. Chockalingam, 1998, Canadian journal of public health = Revue canadienne de sante publique.

Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.

R. Feldman, 1990, British journal of clinical pharmacology.

Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.

E. Schiffrin, G. Bjarnason, C. Kollmannsberger, 2012, Current oncology.

Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent β-arrestin association and indices of inflammation

S. Dixon, R. Hegele, S. Ferguson, 2007, The Pharmacogenomics Journal.

New insights into the regulation of cAMP synthesis beyond GPCR/G protein activation: implications in cardiovascular regulation.

R. Feldman, R. Gros, 2007, Life sciences.

Beyond the shadow: getting past the veil of nonadherence in the management of atherosclerotic risk factors.

T. Campbell, R. Feldman, 2012, The Canadian journal of cardiology.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2012, The Canadian journal of cardiology.

Single Pill Combinations as Initial Therapy in the Management of Hypertension: What is Taking you so Long?

R. Feldman, 2018, American journal of hypertension.

β‐Adrenergic responsiveness is regulated selectively in hypertension

R. Feldman, S. E. Anthony, D. Freeman, 1993 .

Beta-adrenergic responsiveness is regulated selectively in hypertension.

R. Feldman, S. E. Anthony, J. Brown, 1993, Clinical pharmacology and therapeutics.

GPER (GPR30): A Nongenomic Receptor (GPCR) for Steroid Hormones with Implications for Cardiovascular Disease and Cancer.

R. Feldman, L. Limbird, 2017, Annual review of pharmacology and toxicology.

[19] Crosstalk between tyrosine kinase and G-protein-linked signal transduction systems

M. Bouvier, R. Feldman, 1996 .

Copernicus Revisited: Overturning Ptolemy's View of the GPER Universe

R. Feldman, L. Limbird, 2015, Trends in Endocrinology & Metabolism.

Response to Nongenomic Response to Aldosterone

R. Feldman, R. Gros, 2011 .

GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone

L. Sklar, R. Feldman, R. Gros, 2011, Hypertension.

Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30.

R. Feldman, L. Limbird, R. Gros, 2009, American journal of physiology. Cell physiology.

Choreographing the rapid vascular effects of estrogen: sorting out the partners and the steps.

R. Feldman, R. Gros, 2007, Hypertension.

Inhibition of Na-K-Cl cotransport by amiloride analogues is associated with stimulation of cyclic AMP-dependent protein kinase.

S. Dixon, R. Feldman, 1993, Molecular pharmacology.

G-protein function is reduced in hypertension.

R. Feldman, J. Chorazyczewski, 1997, Hypertension.

Photoaffinity labeling in the study of lymphoid cell β-adrenergic receptors

A. Rashidbaigi, R. Feldman, R. Clark, 1987 .

Temperature-dependent binding of hydrophilic beta-adrenergic receptor ligands to intact human lymphocytes.

H. Motulsky, R. Feldman, K. Thede-Reynolds, 1986, Life sciences.

Beta-adrenergic-mediated Cl secretion: evidence for additional non-cAMP-dependent pathway of effect.

M. Welsh, R. Feldman, A. Brotherton, 1990, The American journal of physiology.

Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.

Lawrence A Leiter, A. Logan, R. Haynes, 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Beta-adrenergic receptors on canine coronary collateral vessels: characterization and function.

D. Harrison, R. Feldman, S. Paul, 1989, The American journal of physiology.

Aldosterone and blood pressure regulation: recent milestones on the long and winding road from electrocortin to KCNJ5, GPER, and beyond.

R. Feldman, 2014, Hypertension.

Road From Electrocortin to KCNJ 5 , GPER , and Beyond Aldosterone and Blood Pressure Regulation : Recent Milestones on the Long and Winding

R. Feldman, 2013 .

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

E. Schiffrin, F. McAlister, K. Zarnke, 2002, The Canadian journal of cardiology.

Aldosterone mediates metastatic spread of renal cancer via the G protein‐coupled estrogen receptor (GPER)

J. Pickering, R. Feldman, L. Limbird, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Identification of a novel mechanism for endotoxin‐mediated down‐modulation of CC chemokine receptor expression

D. Kelvin, J. Madrenas, R. Feldman, 2000, European journal of immunology.

Vascular α‐adrenergic responsiveness is reduced in cirrhosis

R. Feldman, P. Adams, G. S. Bierbrier, 1994 .

Identification of a Dysfunctional Missense Single Nucleotide Variant of Human Adenylyl Cyclase VI

R. Hegele, H. Cao, R. Feldman, 2005, Clinical pharmacology and therapeutics.

Review article: Drug development in inflammatory bowel disease: budesonide—a model of targeted therapy

B. Feagan, R. Feldman, R. Hamedani, 1997, Alimentary pharmacology & therapeutics.

Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.

J. Oates, R. Feldman, M. Goldberg, 1982, The Journal of pharmacology and experimental therapeutics.

The Impact of Blunted β-Adrenergic Responsiveness on Growth Regulatory Pathways in Hypertension

R. Hegele, J. Pickering, R. Feldman, 2006, Molecular Pharmacology.

Deactivation of vasodilator responses by GRK2 overexpression: a mechanism or the mechanism for hypertension?

R. Feldman, Ross D Feldman, 2002, Molecular pharmacology.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2007, The Canadian journal of cardiology.

Extracellular nucleotides potentiate the cytosolic Ca2+, but not cyclic adenosine 3', 5'-monophosphate response to parathyroid hormone in rat osteoblastic cells.

S. Dixon, R. Feldman, A. Kaplan, 1995, Endocrinology.

Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism.

D. Kelvin, J. Pickering, C. Kong, 1999, Journal of immunology.

Alternative Chemokine Ligand-Independent Responsiveness in Human Monocytes Via an Down-Modulation of CC Chemokine Bacterial Superantigens Induce

D. Kelvin, J. Pickering, C. Kong, 1999 .

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2010, The Canadian journal of cardiology.

Adenylyl Cyclase Isoform–Selective Regulation of Vascular Smooth Muscle Proliferation and Cytoskeletal Reorganization

Robert Gros, J Geoffrey Pickering, J. Pickering, 2006, Circulation research.

Receptor Expression Mediated Regulation of CXCR1 and CXCR2 Chemokine - Necrosis Factor-? and Tumor - Metalloproteinases Are Involved in Lipopolysaccharide

D. Kelvin, R. Feldman, H. Leung, 2013 .

CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes

D. Kelvin, J. Madrenas, J. Pickering, 1999, European journal of immunology.

Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.

D. Kelvin, J. Madrenas, S. Ferguson, 1999, Blood.

CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.

D. Kelvin, J. Pickering, R. Feldman, 1998, Journal of immunology.

Tyrosine Kinase-Dependent Mechanism Through a Unique Agonist-Independent , Down-Modulated by Bacterial Endotoxin CXCR 1 and CXCR 2 Are Rapidly

D. Kelvin, J. Pickering, R. Feldman, 1998 .

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

P. McFarlane, E. Schiffrin, A. Logan, 2016, The Canadian journal of cardiology.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2008, The Canadian journal of cardiology.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2014, The Canadian journal of cardiology.

Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program

F. McAlister, R. Brant, K. Zarnke, 2003, Journal of hypertension.

Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps

R. Ostrom, R. Feldman, R. Gros, 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

The Effects of Activated Charcoal on Digoxin and Digitoxin Clearance

R. Feldman, R. Spector, M. Goldberg, 1985, Drug intelligence & clinical pharmacy.

Heart Disease in Women: Unappreciated Challenges, GPER as a New Target

R. Feldman, 2016, International journal of molecular sciences.

Mineralocorticoids in the heart and vasculature: new insights for old hormones.

C. Bode, R. Feldman, M. Moser, 2015, Annual review of pharmacology and toxicology.

Vascular effects of aldosterone: Sorting out the receptors and the ligands

R. Feldman, R. Gros, 2013, Clinical and experimental pharmacology & physiology.

Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.

J. Pickering, R. Feldman, R. Gros, 2011, Canadian journal of physiology and pharmacology.

Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways

R. Feldman, R. Gros, 2011, British journal of pharmacology.

What is the basis for the accelerating interest in elucidating how steroid hormones like estradiol and aldosterone mediate their cardiovascular effects ?

R. Feldman, R. Gros, 2011 .

Rapid vascular effects of steroids - a question of balance?

R. Feldman, R. Gros, 2010, The Canadian journal of cardiology.

Rapid effects of aldosterone on clonal human vascular smooth muscle cells.

J. Pickering, R. Feldman, R. Gros, 2007, American journal of physiology. Cell physiology.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Simon L Bacon, Martin G Myers, Michael D Hill, 2011, The Canadian journal of cardiology.

Raf kinase activation of adenylyl cyclases: isoform-selective regulation.

R. Taussig, S. Ferguson, R. Feldman, 2004, Molecular pharmacology.

miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications

S. Chakrabarti, R. Feldman, B. Feng, 2011, Diabetes.

Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines.

R. Feldman, D. Robertson, L. Limbird, 1983, The Journal of clinical investigation.

Adherence to Antihypertensive Medications: Current Status and Future Directions

K. Lavoie, T. Campbell, R. Feldman, 2014, Current Cardiovascular Risk Reports.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2017, The Canadian journal of cardiology.

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels

G. Gensini, T. Jenssen, G. Mancini, 2006, International journal of cardiology.

Treatment of hypertension

R. Feldman, 2013 .

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Lawrence A Leiter, E. Schiffrin, F. McAlister, 2006, The Canadian journal of cardiology.

Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase.

D. Kelvin, D. Litchfield, S. Ferguson, 2001, Biochemistry.

Oxidant stress enhances adenylyl cyclase activation.

R. Feldman, R D Feldman, C M Tan, 1995, Circulation research.

The effectiveness of teaching clinical pharmacokinetics by computer

R. Feldman, R D Feldman, R Schoenwald, 1993, Clinical pharmacology and therapeutics.

A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.

R. Hegele, A. McIntyre, R. Feldman, 2014, British journal of clinical pharmacology.

Common Hyperfunctional Variant of Adenylyl Cyclase 6 Increased Blood Pressure and Hyperdynamic Cardiovascular Responses in Carriers of a

J. Shoemaker, R. Hegele, G. Hodges, 2015 .

Increased Blood Pressure and Hyperdynamic Cardiovascular Responses in Carriers of a Common Hyperfunctional Variant of Adenylyl Cyclase 6

J. Shoemaker, R. Hegele, G. Hodges, 2010, Journal of Pharmacology and Experimental Therapeutics.

Hypertension in Canada: Past, Present, and Future.

E. Schiffrin, R. Padwal, N. Campbell, 2016, Annals of global health.

Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2020, The Canadian journal of cardiology.

4. Recommendations on physical exercise training

R. Petrella, R. Feldman, J. Cléroux, 1999 .

High blood pressure selected as the theme for World Health Day, April 7, 2013: cup half full or half empty?

N. Campbell, R. Feldman, J. Kaczorowski, 2013, The Canadian journal of cardiology.

Applying Atherosclerotic Risk Prevention Guidelines to Elderly Patients: A Bridge Too Far?

R. Hegele, K. Rockwood, S. Harris, 2016, The Canadian journal of cardiology.

Adherence to Management of High Blood Pressure: Recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control

G. Fodor, R. Feldman, A. Chockalingam, 1998, Canadian journal of public health = Revue canadienne de sante publique.

Updated National and International Hypertension Guidelines: A Review of Current Recommendations

B. Williams, S. Kjeldsen, C. Chiang, 2014, Drugs.

Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2)

M. Vandervoort, B. Feagan, R. Feldman, 2013, Journal of hypertension.

Reducing risk with e-based support for adherence to lifestyle change in hypertension (REACH): protocol for a multicentred randomised controlled trial

V. Hachinski, R. Nolan, S. Barr, 2013, BMJ Open.

From bad behaviour to bad biology: pitfalls and promises in the management of resistant hypertension.

R. Feldman, E. Brass, 2013, The Canadian journal of cardiology.

Impact of spironolactone exposure on prostate cancer incidence amongst men with heart failure: A Pharmacoepidemiological study

B. Hiebert, R. Feldman, Rohan M. Sanjanwala, 2020, British journal of clinical pharmacology.

Secretoneurin and chemoattractant receptor interactions

D. O'Connor, D. Kelvin, S. Mahata, 1998, Journal of Neuroimmunology.

A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial

M. Vandervoort, B. Feagan, R. Feldman, 2009, Hypertension.

Regulation of hormone-stimulated cyclic AMP accumulation in intact human mononuclear leukocytes by blood plasma.

H. Motulsky, R. Feldman, B. Terman, 1986, Journal of cyclic nucleotide and protein phosphorylation research.

Vascular alpha-adrenergic responsiveness is reduced in cirrhosis.

R. Feldman, P. Adams, G. S. Bierbrier, 1994, Clinical pharmacology and therapeutics.

Sex-Specific Determinants of Coronary Artery Disease and Atherosclerotic Risk Factors: Estrogen and Beyond.

R. Feldman, 2020, The Canadian journal of cardiology.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

F. McAlister, B. Hemmelgarn, K. Zarnke, 2004, The Canadian journal of cardiology.

G-Protein Estrogen Receptor as a Regulator of Low-Density Lipoprotein Cholesterol Metabolism: Cellular and Population Genetic Studies

R. Hegele, A. McIntyre, R. Feldman, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Hypertension Canada's 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension

Lawrence A Leiter, P. McFarlane, A. Logan, 2016 .

Beta-adrenergic receptor alterations in hypertension--physiological and molecular correlates.

R. Feldman, 1987, Canadian journal of physiology and pharmacology.

Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis

L. Howes, T. Jenssen, F. Hobbs, 2012, Current medical research and opinion.

International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme

G. Gensini, T. Jenssen, G. Mancini, 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

The History of Hypertension Guidelines in Canada.

F. McAlister, S. Daskalopoulou, D. Rabi, 2019, The Canadian journal of cardiology.

What is the Connection Between Hypertension , Headache and Migraine ?

E. Schiffrin, R. Ogilvie, S. Rabkin, 2006 .

Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist

H. Motulsky, R. Feldman, L. Limbird, 2022, Pharmacology research & perspectives.

Down the Rabbit Hole: Hypertension Guidelines, Goals and Gulfs Across the 49th Parallel.

R. Feldman, 2018, The Canadian journal of cardiology.

Hypertension guidelines: criteria that might make them more clinically useful.

N. Campbell, R. Feldman, D. Drouin, 2003, American journal of hypertension.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Alexander G Logan, Pierre Larochelle, Malcolm Arnold, 2005, The Canadian journal of cardiology.